A Phase 2, Double-Blind, Proof of Concept Study to Evaluate Mazdutide Compared with Placebo in Participants with Alcohol Use Disorder

Date Added
April 23rd, 2025
PRO Number
Pro00142519
Researcher
Sarah Book

List of Studies


Keywords
Substance Use
Summary

This is a 28-week-long treatment study for people with Alcohol Use Disorder who want to stop or cut down their drinking. The purpose of this study is to determine whether an investigational medication, Mazdutide, affects craving for alcohol and/or alcohol drinking while taking the study drug. Participants will be randomly assigned to Mazdutide or a matched placebo

Institution
MUSC
Recruitment Contact
Konstantin Voronin
843-792-4887
voronin@musc.edu



-- OR --